Literature DB >> 12193856

[Split-liver transplantation in two adult recipients: evaluation of feasibility in 100 consecutive cadaver liver grafts].

Gilles Poncet1, Jérôme Dumortier, Antoine Choucair, Marwan Dawahra, Catherine Boucaud, Jean-Yves Scoazec, Olivier Boillot.   

Abstract

AIM: To evaluate the feasibility of splitting a liver graft for transplantation in two adult patients. PATIENTS AND METHODS: We retrospectively collected data on the harvesting of 100 consecutive liver grafts. Data were separated into 4 groups to establish feasibility criteria, according to the chronological steps of harvesting: 1) initial criteria about the donor (age, weight, biological tests), 2) criteria concerning the liver graft at the time of harvesting (macroscopic appearance, graft weight, hemodynamic state of donor), (3) anatomical criteria and (4) histological criteria.
RESULTS: If our criteria for the feasibility of splitting a liver graft for transplantation in two adults had been applied, 47 grafts would have been rejected based on initial criteria, 34 at the time of harvesting and 6 because of anatomical or histological evaluation. Finally, 13 liver grafts would have been accepted for splitting and then transplantation in two adults.
CONCLUSIONS: Split-liver transplantation for two adult recipients could increase the graft pool by 13%. This procedure requires technical changes in organ harvesting and coordination among centers.

Entities:  

Mesh:

Year:  2002        PMID: 12193856

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

1.  Technical refinements and results in full-right full-left splitting of the deceased donor liver.

Authors:  Dieter C Broering; Christian Wilms; Christian Lenk; Jan Schulte am Esch; Silke Schönherr; Lars Mueller; Jong-Sun Kim; Knut Helmke; Martin Burdelski; Xavier Rogiers
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

2.  Split liver transplantation.

Authors:  D C Broering; J Schulte am Esch; L Fischer; X Rogiers
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.